Literature DB >> 19088003

Carcinoid tumors: what should increase our suspicion?

Gaurav Aggarwal1, Kamil Obideen, Mohammad Wehbi.   

Abstract

Carcinoid tumors are neuroendocrine neoplasms, primarily of the gastrointestinal tract. Their incidence has been increasing over the last 2 to 3 decades. Patients often present with vague, nonspecific symptoms. Thus, primary care physicians should keep this diagnosis in mind and start appropriate diagnostic testing if they suspect it on a clinical basis. Patients with carcinoid tumors are also at increased risk of developing other malignancies, so close follow-up by their primary care physician is necessary.

Entities:  

Mesh:

Year:  2008        PMID: 19088003     DOI: 10.3949/ccjm.75a.08002

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  8 in total

1.  Primary aldosteronism due to adrenocortical adenoma with concurrent ileum carcinoid tumor: case report.

Authors:  L Zinnamosca; L Petramala; D Cotesta; C Marinelli; S Sciomer; G Cavallaro; A Ciardi; R Massa; G De Toma; S Filetti; C Letizia
Journal:  Endocrine       Date:  2010-12       Impact factor: 3.633

2.  Diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors: current data on a prospectively collected, retrospectively analyzed clinical multicenter investigation.

Authors:  Martin B Niederle; Bruno Niederle
Journal:  Oncologist       Date:  2011-04-05

3.  Neurotensin, a novel target of Wnt/β-catenin pathway, promotes growth of neuroendocrine tumor cells.

Authors:  Ji Tae Kim; Chunming Liu; Yekaterina Y Zaytseva; Heidi L Weiss; Courtney M Townsend; B Mark Evers
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

4.  Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  David E Ost; Sai-Ching Jim Yeung; Lynn T Tanoue; Michael K Gould
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

5.  Factors associated with survival of veterans with gastrointestinal neuroendocrine tumors.

Authors:  Bryan L Balmadrid; Catherine M Thomas; Cynthia J Coffman; Rodger A Liddle; Deborah A Fisher
Journal:  J Cancer Epidemiol       Date:  2012-05-27

6.  Delayed recurrence of atypical pulmonary carcinoid cluster: a rare occurrence.

Authors:  Salim Surani; Jennifer Tan; Alexandra Ahumada; Saherish S Surani; Sivakumar Sudhakaran; Joseph Varon
Journal:  Case Rep Pulmonol       Date:  2014-11-18

7.  Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors.

Authors:  Merete Gedde-Dahl; Espen Thiis-Evensen; Andreas Myklebust Tjølsen; Kjerstin Skrede Mordal; Morten Vatn; Deidi S Bergestuen
Journal:  Endocr Connect       Date:  2013-01-25       Impact factor: 3.335

Review 8.  A rare case of metachronous neuroendocrine tumor after a colorectal adenocarcinoma: qualitative critical review of synchronous and metachronous gastrointestinal NET.

Authors:  Francesco Lancellotti; Luigi Solinas; Davide Telesco; Andrea Sagnotta; Augusto Belardi; Giuseppina Balsamo; Stefano Mancini
Journal:  Clin J Gastroenterol       Date:  2020-10-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.